Summary
Fulminant, necrotizing colitis is a frequent, and generally fatal, complication of severe granulocytopenia, occurring during the treatment of hematological malignancies. In these cases, the patient complains of severe peritonitis, including nausea, vomiting, abdominal pain, diarrhea or melena, and a high temperature. Here, a rare case of anticancer chemotherapy-induced diffuse necrotizing enterocolitis throughout the entire intestinal tract is presented, which developed in a patient who did not have a hematologic malignancy but who had colon cancer, the only clinical symptom of which was watery stools, without any evidence of peritoneal irritation. Full attention should be paid to progressive diarrhea in patients with malignancies during anticancer chemotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kundel JM, et al: Management of the ileocecal syndrome. Neutropenic enterocolitis. Dis Col Rect 1986, 29: 196
Harwich G: Side effects of a cytostatic treatment on the gastrointestinal tract. Acta Hepato-Gastroenterol 1974, 21: 89
Bartlett JG, et al: Antibiotic associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 1978, 298: 531
Choie DD, et al: Mitigation of intestinal cytotoxicity of cisplatin by EDTA in rats. Cancer Letters 1983, 19: 195
Cloebunders R, et al: A patient with testis seminosa, sarcoidosis and neutropenic enterocolitis. Human Pathology 1984, 15: 394
Varki AP, et al: Typhilitis in acute leukemia. Successful treatment by early surgical intervention. Cancer 1979, 43: 695
Gandy W, et al: Successful medical management of neutropenic enterocolitis. Cancer 1983, 51: 1551
Dosik GM, et al: Necrotizing colitis in patients with cancer. Am J Med 1979, 67: 646
Starnes Jr HF, et al: Abdominal pain in neutropenic cancer patients. Cancer 1986, 57: 616
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maeta, M., Mizusawa, K. & Koga, S. Induction of diffuse necrotizing enterocolitis by anticancer chemotherapy. Gastroenterol Jpn 22, 370–373 (1987). https://doi.org/10.1007/BF02774263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774263